Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Recruiting1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT05476770Phase 1Recruiting
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Acute Undifferentiated LeukemiaALLAML+8 more
StudychairStart date: 2022-11-11

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Related
14 trials

Shared therapeutic areas:

AmlLymphoma, B-CellHematologic Neoplasms+1 more
Similarity Score11%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaMDSAml+1 more
Similarity Score11%

Farhad Ravandi-Kashani, MD

M.D. Anderson Cancer Center

Related
14 trials

Shared therapeutic areas:

AmlPrecursor Cell Lymphoblastic Leukemia-LymphomaHematologic Neoplasms
Similarity Score8%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Lymphoma, B-CellHodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score8%

Elias Jabbour

M.D. Anderson Cancer Center

Related
15 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaAcute Undifferentiated LeukemiaMixed Phenotype Acute Leukemia
Similarity Score8%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Hematologic NeoplasmsHodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score8%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaHodgkin DiseaseLymphoma, B-Cell
Similarity Score8%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLymphoma, B-Cell
Similarity Score5%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Hematologic NeoplasmsAml
Similarity Score5%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Hematologic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05476770Phase 1StudyChair

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Acute Undifferentiated LeukemiaALLAML+8 more
Recruiting

All 1 trials loaded